ƒƒ_ƒ‰ƒVƒ“”Z“x‚Ì‘ª’è‚É‚æ‚鑽”­«d‰»Ç‚Ìf’f

Â@–Ø@—m@—S*1@Ö@“c@F@•F*2@’†@–ì@¡@Ž¡*3@Ä@“¡@–L@˜a*4
’r@Œû@–M@•F*5@ƒg@•”@‹M@•v*6@¼@Œû@‰x@Žq*7@—é@–Ø@‰p@–¾*8
‚@‹´@Ž÷@—R*9@…@–ì@”ü@–M*10@@@@@@@@@@@@@@@@ @@@@@
@@@@@@@@@@@@@@@@@@@@@@
Determination of Medullasin Levels for the Diagnosis of Multiple Sclerosis

Yosuke AOKI, MD*1, Takahiko SAIDA, MD*2, Imaharu NAKANO, MD*3, Toyokazu SAITO, MD*4,
Kunihiko IKEGUCHI, MD*5, Takao URABE, MD*6, Etsuko NISHIGUCHI*7,
Hideaki SUZUKI, PhD*8, Kiyoshi TAKAHASHI*9 and Yoshikuni MIZUNO, MD*10

Medullasin levels in granulocytes of patients with neurological diseases and healthy volunteers were determined by the enzyme immunoassay using mouse monoclonal antibodies against human medullasin and o-phenylenediamine-H2O2 as the detection system of the enzyme activity. One hundred twenty-one out of 159 patients with multiple sclerosis(76.1%) showed positive results(above means of normals{2SD) in this test, while only 16.9%(24/142) of patients with non-inflammatory neurological diseases had positive results. This enzyme immunoassay method for medullasin is considered to be an useful paraclinical test for the diagnosis of multiple sclerosis.
[Rinsho Byori 50 : 308`312, 2002]

*1Department of Food and Health Science, Faculty of Human Life Science, Jissen Women's University, Hino 191-8510

yKey Wordszmedullasin(ƒƒ_ƒ‰ƒVƒ“)Cmultiple sclerosis(‘½”­«d‰»Ç)Cenzyme immunoassay(y‘f–Ɖu‘ª’è–@)Cgranulocytes(è÷—±‹…)
@@@@@@@@@@@@@@@@@@@@@@@@@
Žó•t2001”N10ŒŽ18“úEŽó—2001”N12ŒŽ13“ú
*1ŽÀ‘H—Žq‘åŠw¶Šˆ‰ÈŠw•”(§191-8510 “ú–ìŽs‘åâã4-1-1)
*2,7‘—§—×{ЉF‘½–ì•a‰@(§616-8255 ‹ž“sŽs‰E‹ž‹æ–‘ꉹŒËŽR8)
*3,5ީޡˆã‰È‘åŠw_Œo“à‰È(§329-0498 “È–ØŒ§‰Í“àŒS“ì‰Í“à’¬–òŽtŽ›3311-1)
*4–k—¢‘åŠw“Œ•a‰@_Œo“à‰È(§228-8520 ‘Š–ÍŒ´Žs–ƒa‘ä2-1-1)
*6,10‡“V“°‘åŠw”]_Œo“à‰È(§113-8431 “Œ‹ž“s•¶‹ž‹æ–{‹½2-1-1)
*8,9‘å“ú¸‰»H‹ÆŠ”Ž®‰ïŽÐ(§103-8383 “Œ‹ž“s’†‰›‹æ“ú–{‹´”n‹ò’¬1-7-6)

E-mail :yaoki@univ.jissen.ac.jp